In addition, many third-generation antibodies designed to trigger different mechanisms of action simultaneously (such as targeting growth factors, inhibiting angiogenesis and restoring apoptosis ...

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

Bispecific antibodies, which bind simultaneously to two different antigens, can attack tumors via novel mechanisms of action that cannot be evoked with combinations of conventional monoclonal ...

It is composed of the antibody binding fragment (Fab) of humanized monoclonal antibody against TNF conjugated to polyethylene glycol; therefore, unlike other agents, it does not contain the ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...